Search Results
Showing 1-3 of 3 Resources
-
Gleevec-Resistant Form of Kinase BCR-ABL(2 min 14 sec) Mutations in the BCR-ABL gene can cause resistance to Gleevec, but another drug, dasatinib, can be used instead.
-
Gleevec Inhibits Cancer-Causing Kinase BCR-ABL(3 min 31 sec) The drug Gleevec binds to and inactivates BCR-ABL, a mutant kinase that causes chronic myeloid leukemia.
-
The LUX operon controls light production(2 min 25 sec) A single transcription factor controls this operon, which contains five genes necessary to produce bioluminescence.
Refine Results
Narrow your choices by selecting areas below.